Pfizer Spends Big on IP Lobbying With Billions on the Line
The pharmaceutical giant spent big bucks amid key international negotiations last year to protect record earnings.
Big Pharma
Corporate Dems’ Rapidly Growing ‘Dark Money’ Arm
Tax documents reveal the group Center Forward received a record $18.8 million in 2021 and spent big to back conservative Democrats who bucked their party on drug pricing reforms.
News Outlet Founded by Blue Dog Dem Operatives Promotes Big Pharma's Lobbying Aims
Leaders of a centrist advocacy group with funding from the pharmaceutical industry founded outlet The Well News and have editorial input on its promoted posts.
Pharma Companies Spend Billions More on Stock Buybacks Than Developing Drugs, House Report Finds
The largest drugmakers spent $56 billion more on stock buybacks and dividends than on research and development from 2016 to 2020, according to a new House committee report.
Dems Signaling Opposition to Pelosi’s Drug Pricing Bill Got 2.5x More Pharma Money
On average, the signers received $93,275 from the pharmaceutical & health products industry in the 2020 cycle, far more than the average for House Democrats of $37,788.
Koch Group Fights Drug Price Reforms After Taking Big Pharma Money
Americans for Prosperity is hitting six key moderate House Democrats with digital ads opposing reintroduced drug pricing measures.
Blue Dog-Affiliated Group Runs Ads for Big Pharma
Center Forward, a "dark money" group with major funding from Big Pharma, is running a Facebook ad campaign touting the pharmaceutical industry as its super PAC spends millions to re-elect Blue Dog Democrats.